Scientific Sessions 2024  /  Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure  /  Discussant: REALIZE-K
Logo

American Heart Association

  137
  0

Final ID:

Discussant: REALIZE-K

  • Zannad, Faiez  ( CVCT and Universite de Lorraine , Paris , France )
  • Allen, Larry  ( UNIVERSITY COLORADO DENVER , Aurora , Colorado , United States )
    • Author Disclosures:
    Faiez ZANNAD: DO have relevant financial relationships ; Advisor:NovoNordisk:Past (completed) ; Advisor:Northsea:Expected (by end of conference) ; Advisor:Merck:Active (exists now) ; Advisor:CEVA:Past (completed) ; Advisor:Cellprothera:Active (exists now) ; Advisor:Cereno:Active (exists now) ; Ownership Interest:CVCT:Active (exists now) ; Advisor:Cardior:Past (completed) ; Advisor:CVRx:Active (exists now) ; Advisor:BMS:Past (completed) ; Advisor:Boehringer:Active (exists now) ; Advisor:Biopeutics:Active (exists now) ; Consultant:Owkin:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Advisor:Applied Therapeutics:Past (completed) | Larry Allen: DO have relevant financial relationships ; Consultant:ACI Clinical:Active (exists now) ; Researcher:PCORI:Active (exists now) ; Researcher:NIH:Active (exists now) ; Consultant:UpToDate:Active (exists now) ; Consultant:Quidel:Active (exists now) ; Consultant:Novartis:Past (completed) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Boston Scientific:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure

Monday, 11/18/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Myeloperoxidase Inhibition with Mitiperstat in Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Primary Results from the ENDEAVOR Randomized Clinical Trial

Lund Lars, Lam Carolyn, Ely Pizzato Patricia, Michaëlsson Erik, Mattsson Andrea, Ericsson Hans, Baldus Stephan, Shah Sanjiv

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial – The SARAH Trial

Bonatto Marcely, Zaninelli Maiolino Julyana, Mosko Larissa Arlete, Mialski Talita, Ota Tammy, Moura Lidia, Cauduro Sanderson, Bocchi Edimar, Ferreira Silvia, Avila Monica, Lechinewski Luka, Torres Rafael, Costa Amanda, Coiradas Andressa, Costa Nadya, Contin Lais

More abstracts from these authors:
Discussant

Allen Larry

Enhancing Safety and Utilization of Remote Cardiac Rehabilitation

Allen Larry

You have to be authorized to contact abstract author. Please, Login
Not Available